97668847 - TRIUMPH

Information

• Trademark
• 97668847

• Source

• Serial Number

  97668847

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 08, 2022
  2 years ago

• Transaction Date

  February 05, 2025
  2 months ago

• Status Date

  February 04, 2025
  2 months ago

• Published for Opposition Date

  December 19, 2023
  a year ago

• Location Date

  February 13, 2024
  a year ago

• Status Code

  731

• Current Location

  INTENT TO USE SECTION

  Employee Name

  MCMORROW, JANICE

• Attorney Name

  Nancy Sabarra

  Law Office Assigned Location Code

  M60

• Owners

  • Seqirus Pty Ltd

Case File Statements

• GS0051: Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
• GS0011: Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use
• GS0441: Medical services; medical information; providing a website featuring medical information
• GS0421: Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Case File Event Statements

• 12/15/2022 - 2 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 11/11/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/29/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/21/2023 - 2 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 2/21/2023 - 2 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 5/15/2023 - a year ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 5/22/2023 - a year ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/22/2023 - a year ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/22/2023 - a year ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/16/2023 - a year ago

  10 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/16/2023 - a year ago

  11 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 11/13/2023 - a year ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/13/2023 - a year ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/14/2023 - a year ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/15/2023 - a year ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/29/2023 - a year ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/19/2023 - a year ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/19/2023 - a year ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/2/2024 - 8 months ago

  20 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/2/2024 - 8 months ago

  22 - SOU EXTENSION 1 GRANTED Type: EX1G

• 8/2/2024 - 8 months ago

  21 - SOU EXTENSION 1 FILED Type: EXT1

• 2/13/2024 - a year ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/2/2024 - 8 months ago

  23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/4/2025 - 2 months ago

  24 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/4/2025 - 2 months ago

  25 - SOU EXTENSION 2 FILED Type: EXT2

• 2/5/2025 - 2 months ago

  26 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/5/2025 - 2 months ago

  27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA